SFS
ANIP icon

Sowell Financial Services’s ANI Pharmaceuticals ANIP Stock Holding History

Sowell Financial Services’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,256
Closed -$343K – 1074
2025
Q2 		$343K Sell
5,256
-6
-0.1% -$391 0.01% 731
2025
Q1 		$352K Buy
+5,262
New +$314K 0.02% 698
2023
Q2 		– Sell
-5,926
Closed -$235K – 567
2023
Q1 		$235K Buy
+5,926
New +$250K 0.02% 645
2021
Q2 		– Sell
-6,229
Closed -$218K – 618
2021
Q1 		$218K Buy
6,229
+6,226
+207,533% +$195K 0.01% 1003
2020
Q4 		$0 Hold
3
– – ﹤0.01% 2682
2020
Q3 		$0 Sell
3
-1,229
-100% -$36.6K ﹤0.01% 2508
2020
Q2 		$40K Hold
1,232
– – ﹤0.01% 1227
2020
Q1 		$50K Buy
1,232
+1,224
+15,300% +$65.1K ﹤0.01% 1057
2019
Q4 		$0 Hold
8
– – ﹤0.01% 2504
2019
Q3 		$1K Buy
+8
New +$599 ﹤0.01% 2183
2017
Q1 		– Sell
-8
Closed -$1K – 268
2016
Q4 		$1K Buy
+8
New +$489 ﹤0.01% 605

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Sowell Financial Services's ANIP Position: Q3 2025 in Review

Sowell Financial Services sold out of ANI Pharmaceuticals (ANIP) in Q3 2025, closing a stake of 5,256 shares — an estimated $343K sold.

Sowell Financial Services first reported a position in ANIP in Q4 2016 and held it in 11 quarters. The position peaked at $352K in Q1 2025. 269 funds tracked by Wall St. Rank hold ANIP as of Q3 2025.

  • Sowell Financial Services reported no remaining ANI Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Sowell Financial Services sold 5,256 ANI Pharmaceuticals shares in Q3 2025, an estimated $343K.
  • Sowell Financial Services first reported a position in ANI Pharmaceuticals in Q4 2016 and held it in 11 quarters.
  • Sowell Financial Services's ANI Pharmaceuticals position peaked at $352K in Q1 2025.
  • 269 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2025.

Based on Sowell Financial Services's 13F filing for Q3 2025, filed 17 Oct 2025.